Volume 4, Issue 3, September 2023

View Volume 4, Issue 3, September 2023

Tebentafusp: A New Systemic Treatment for Unresectable or Metastatic Uveal Melanoma in HLA-A*02:01-Positive Patients
Psoriasiform and Eczematous Paradoxical Reactions to Biologic Agents
Use of Neuromodulators as Aesthetic Treatment in the Lower Face
A Practical Guide to Non-insured Health Benefits (NIHB) for Dermatologists Caring for Status First Nations and Inuit Peoples of Canada
Strategies to Optimize Outcomes and Prevent Complications with Lasers

Published: 2023-09-29

Full Issue

Articles

Use of Neuromodulators as Aesthetic Treatment in the Lower Face

Malika Ladha, MD, FRCPC

21–25
- PDF (en)
- PDF (fr)
Tebentafusp: A New Systemic Treatment for Unresectable or Metastatic Uveal Melanoma in HLA-A*02:01-positive patients

Cynthia Fournier, MD, FRCPC

5–10
- PDF (en)
- PDF (fr)
A Practical Guide to Non-insured Health Benefits (NIHB) for Dermatologists Caring for Status First Nations and Inuit Peoples of Canada

Rachel Asiniwasis, MD, MS(HS), FRCPC

27–37
- PDF (en)
- PDF (fr)
Psoriasiform and Eczematous Paradoxical Reactions to Biologic Agents

Asfandyar Mufti, MD, FRCPC

12–20
- PDF (en)
- PDF (fr)
Strategies to Optimize Outcomes and Prevent Complications with Lasers

Vincent Richer, MD, FRCPC

39–46
- PDF (en)
- PDF (fr)